Glycemic Excursions in Type 2 Diabetic Patients With Vildagliptin and Metformin Versus Vildagliptin and Glimepiride

NCT02007278 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes
Hypoglycemia

Interventions

DRUG: vildagliptin and metformin (combination)
DRUG: glimepiride
DRUG: Metformin

Sponsor

Novartis Pharmaceuticals